anmelden
NYSE International 100
11.088,78
PKT
+25,18
PKT
+0,23
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.25 | Philips Neutral | JP Morgan Chase & Co. | |
| 03.02.25 | Diageo Buy | Jefferies & Company Inc. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Mercedes-Benz Group (ex Daimler) Outperform | RBC Capital Markets | |
| 03.02.25 | HSBC Sector Perform | RBC Capital Markets | |
| 03.02.25 | Novartis Hold | Deutsche Bank AG | |
| 03.02.25 | Novartis Kaufen | DZ BANK | |
| 03.02.25 | Unilever Sell | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 03.02.25 | Sanofi Buy | UBS AG | |
| 03.02.25 | HSBC Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | HSBC Hold | Deutsche Bank AG | |
| 03.02.25 | Mercedes-Benz Group (ex Daimler) Hold | Jefferies & Company Inc. | |
| 03.02.25 | Nokia Hold | Jefferies & Company Inc. | |
| 31.01.25 | Deutsche Bank Overweight | Barclays Capital | |
| 31.01.25 | Sanofi Kaufen | DZ BANK | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.01.25 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Deutsche Bank Outperform | RBC Capital Markets | |
| 31.01.25 | Deutsche Bank Kaufen | DZ BANK | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 31.01.25 | Nokia Neutral | UBS AG | |
| 31.01.25 | Philips Neutral | UBS AG | |
| 31.01.25 | BBVA Buy | Deutsche Bank AG | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Nokia Buy | Deutsche Bank AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. |
